| Literature DB >> 34305157 |
A Morales Viera1, R Rivas Rodríguez2, P Otero Aguilar3, E Briones Pérez de Blanca4,5.
Abstract
Background: Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2 infection, spreads swiftly in nursing homes and assisted living facilities, leading to a high degree of lethality. The data generated by an epidemiological surveillance program allow for obtaining valid information on the diseases' epidemiology and possible prevention methods. Objective: This work aims to analyze COVID-19 epidemiology among healthcare staff based in the Seville healthcare district (Spain) and evaluate its role in outbreaks in nursing homes.Entities:
Keywords: COVID-19; Epidemiology; Nursing homes; Nursing staff
Year: 2021 PMID: 34305157 PMCID: PMC8285272 DOI: 10.1016/j.rce.2021.06.005
Source DB: PubMed Journal: Rev Clin Esp ISSN: 0014-2565 Impact factor: 3.064
Figura 1Curva epidémica PSS y residentes (frecuencia relativa).
Tasa de ataque en PSS según centro sociosanitario
| Centro sociosanitario | N.o casos | Plantilla laboral | Tasa de ataque | IC (95%) |
|---|---|---|---|---|
| A | 44 | 122 | 36,1% | 27,4-44,7 |
| B | 23 | 110 | 20,9% | 13,2-28,6 |
| C | 18 | 68 | 26,5% | 15,7-37,2 |
| D | 11 | 62 | 17,7% | 8,0-27,5 |
| E | 8 | 24 | 33,3% | 13,0-53,7 |
| F | 7 | 57 | 12,3% | 3,5-21,1 |
| G | 6 | 103 | 5,8% | 1,2-10,4 |
| H | 1 | 40 | 2,5% | −2,6-7,6 |
| I | 1 | 30 | 3,3% | −3,5-10,2 |
| J | 1 | 21 | 4,8% | −5,2-14,7 |
| K | 1 | 18 | 5,6% | −6,2-17,3 |
| L | 1 | 19 | 5,3% | −5,8-16,3 |
| M | 1 | 11 | 9,1% | 11,2-29,3 |
| N | 1 | 47 | 2,1% | −2,2-6,4 |
| Total | 124 | 732 | 16,9% | 14,2-19,7 |
IC: intervalo de confianza.
Características clínicas y demográficas de casos confirmados en PSS por residencia asociada a brote
| A | B | C | D | E | F | G | Total | |
|---|---|---|---|---|---|---|---|---|
| 30,5 (25,2-37) | 34 (27-52) | 35 (27,2-53) | 44 (39-57) | 37 (30,5-52) | 40 (30-45) | 24,5 (21-33) | 33,5 (27-45) | |
| 32,7 (9,9) | 38,5 (15,1) | 38,9 (13,1) | 44,0 (12,3) | 39,7 (11,8) | 38,8 (7,6) | 26,5 (6,1) | 36,8 (12,2) | |
| Mujer, n (%) | 40 (90,9) | 17 (73,9) | 11 (61,1) | 8 (72,7) | 7 (87,5) | 7 (100) | 4 (66,7) | 98 (79) |
| 38 (86,4) | 19 (82,6) | 17 (94,4) | 10 (90,9) | 5 (62,5) | 7 (100) | 5 (83,3) | 108 (87,1) | |
| Fiebre, n (%) | 14 (31,8) | 7 (30,4) | 5 (27,8) | 4 (36,4) | 1 (12,5) | 2 (28,6) | 2 (33,3) | 39 (31,5) |
| Tos, n (%) | 25 (56,8) | 11 (47,8) | 10 (55,6) | 6 (54,5) | 3 (37,5) | 3 (42,9) | 1 (16,7) | 61 (49,2) |
| Disnea, n (%) | 6 (13,6) | 2 (8,7) | 1 (5,6) | 0 | 1 (12,5) | 0 | 0 | 10 (8,1) |
| Febrícula, n (%) | 6 (13,6) | 2 (8,7) | 1 (5,6) | 1 (9,1) | 1 (12,5) | 1 (14,3) | 0 | 13 (10,5) |
| Cefalea, n (%) | 16 (36,4) | 2 (8,7) | 1 (5,6) | 6 (54,5) | 3 (37,5) | 2 (28,6) | 1 (16,7) | 31 (25) |
| Vómitos/diarrea, n (%) | 3 (6,8) | 2 (8,7) | 3 (16,7) | 1 (9,1) | 0 | 1 (14,3) | 1 (16,7) | 12 (9,7) |
| Odinofagia, n (%) | 5 (11,4) | 3 (13) | 2 (11,1) | 3 (27,3) | 1 (12,5) | 2 (28,6) | 0 | 18 (14,5) |
| Anosmia/ageusia, n (%) | 10 (22,7) | 2 (8,7) | 1 (5,6) | 2 (18,2) | 2 (25) | 2 (28,6) | 3 (50) | 24 (19,4) |
| Astenia/mialgias, n (%) | 9 (20,5) | 4 (17,4) | 0 | 4 (36,4) | 2 (25) | 1 (14,3) | 2 (33,3) | 23 (18,5) |
| 3 (6,8) | 7 (30,4) | 5 (27,8) | 3 (27,3) | 1 (12,5) | 1 (14,3) | 1 (16,7) | 22 (17,7) | |
| 5 (11,4) | 0 | 1 (5,6) | 0 | 0 | 1 (14,3) | 0 | 7 (5,6) | |
| 29 (65,9) | 18 (78,3) | 17 (94,4) | 6 (54,5) | 4 (50) | 7 (100) | 5 (83,3) | 90 (72,6) | |
| 15 (32,6) | 5 (21,7) | 1 (5,6) | 5 (45,5) | 4 (50) | 0 | 1 (16,7) | 34 (27,4) | |
DE: desviación estándar; PCR: reacción en cadena de la polimerasa; RIC: rango intercuartílico.
Figura 2Distribución de casos de PSS por semanas e incidencia acumulada.
Figura 3Media de días de demora entre: fechas de inicio de síntomas (FIS) y aislamiento; FIS y declaración de casos de PSS.